Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion type Assertion NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_head.
- NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion description "[In contrast, the only two missense mutations located in the amino-terminal half of mature frataxin (D122Y and G130V) cause an atypical and milder clinical presentation (early-onset spastic gait with slow disease progression, absence of dysarthria, retained or brisk tendon reflexes, and mild or no cerebellar ataxia), suggesting that they only partially affect frataxin function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_provenance.
- NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion evidence source_evidence_literature NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_provenance.
- NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion SIO_000772 9989622 NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_provenance.
- NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion wasDerivedFrom befree-20140225 NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_provenance.
- NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_assertion wasGeneratedBy ECO_0000203 NP801994.RAvupbl7W-nGbjP_YMF4fmSt4T9FiR2XqZEXX0J-zPsgc130_provenance.